Clinical Trials Results - National Cancer Institute

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results

Last Modified: 1/15/2008 First Published: 2/21/2006


1.		Phase I/II Study of High-Dose Calcitriol and Temozolomide in Patients With Metastatic Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI, Pharmaceutical / Industry				NU-05M1 NU-0310-093, SPRI-NU-05M1, NCT00301067

Last Modified: 5/8/2007 First Published: 5/1/2007


2.		Phase I/II Study of Calcitriol, Cisplatin, and Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Active				Over 18				NCI				RPCI-I-83706 NCT00470431, I 83706

Last Modified: 12/14/2007 First Published: 9/26/2007


3.		Phase I/II Study of Calcitriol, Ketoconazole, and Hydrocortisone in Patients With Advanced or Recurrent Androgen-Independent Prostate Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				NCI				RPCI-I-68905 I 68905, NCT00536991

Last Modified: 7/21/2008 First Published: 5/28/2004


4.		Phase II Randomized Pilot Study of Calcitriol and Dexamethasone Before Radical Prostatectomy in Patients With Localized Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				RPCI-RP-0212 NCT00084864


5.		Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				No age specified				Other				FD-R-2025-01 FD-R-002025-01, NCT00030069


6.		The Role of Calcipotriol as Radioprotector of Skin

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Approved-not yet active				18 to 75				Other				004253 NCT00445250

Last Modified: 8/27/2008 First Published: 6/3/2008


7.		Phase I Pilot Study of Calcitriol in Smokers or Former Smokers With Squamous Metaplasia or Squamous Dysplasia of the Lungs

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Prevention				Active				40 to 79				NCI				RPCI-I-90206 I 90205, NCT00690924

Select All on One Page